Over time, e-detailing
has progressed far beyond using the internet to detail drugs to physicians via e-mail.
With the arrival of devices such as the iPad, e-Detailing
suddenly becomes viable.
Launched in November 2001, the e-Detailing
service has provided useful information on a variety of drugs ranging from antihypertensives and antidiabetics to antitumor agents and antianxiety drugs, and supports medical professionals across Japan.
He points to connectivity applications (linking pharmacies to other players), the recruitment of patients for clinical trials and E-detailing
(targeting doctors) as among emerging Internet uses.
Even more important is the fact that Pfizer recognised our BookVision CLM as a huge step forward how CLM and e-Detailing
should look like.